After the ebola outbreak in 2014, there has been lot of research for the development of a vaccine to prevent the disease. An Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns in the phase 1 randomized controlled trial. High antibodies were present in participants 6 months after immunization.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer